LLY News and Press, Eli Lilly and Company From 05/05/24

2024-05-05 14:49:00 ET A company's track record for paying dividends is a good indicator of how versatile and adaptable the business is in dealing with changing economic conditions. That doesn't mean that the dividend will always be safe and that payouts will always continue, but it's an im...

2024-05-05 06:55:00 ET Don't believe the adage to "sell in May and go away." Buying stocks can still be a smart move, especially if you're a long-term investor. Three Motley Fool contributors have identified stocks they think are no-brainers to buy in May. Here's why they picked Eli L...

2024-05-04 16:47:00 ET The healthcare sector had 24 companies reporting their quarterly earnings this week, with 16 of them beating their topline numbers for the quarter.... Read the full article on Seeking Alpha For further details see: 16 out of 24 health care companies be...

2024-05-04 15:30:00 ET Read the full article on Seeking Alpha For further details see: Pharma R&D productivity seen improving for the first time in years - Deloitte

2024-05-04 11:30:00 ET Summary Eli Lilly and Company delivered robust Q1 earnings, leading to an initial post-earnings surge in LLY stock. However, LLY has lost buying momentum, as selling intensity has overtaken Lilly's earnings euphoria. Eli Lilly is still well-positioned to...

2024-05-04 09:13:02 ET Summary Amgen's shares surged after management's earnings call comments about the phase 2 trial of obesity candidate MariTide. These comments and previous phase 2 data point to the increasing possibility of Amgen becoming a real contender in the rapidly expa...

2024-05-04 08:30:00 ET The pharmaceutical industry is currently experiencing something of a renaissance thanks to the rise of blockbuster medications called glucagon-like peptide-1 (GLP-1) agonists. Perhaps the most well-known GLP-1 drugs are diabetes medication Ozempic and obesity care...

2024-05-04 05:26:00 ET Eli Lilly (NYSE: LLY) stock has been a top performer thanks to runaway sales of its diabetes-turned-weight-management treatment. Despite nearly doubling over the past 12 months, Eli Lilly stock still has heaps of upside according to investment bank analyst...

2024-05-04 04:34:12 ET Summary The momentum factor has slowed recently, despite strong performance driven by AI and semiconductor stocks. Invesco S&P 500 Momentum ETF focuses on domestic large caps and may miss out on global equities and further alpha from Chinese stocks. ...

2024-05-03 16:00:00 ET Summary As the wider market turns pessimistic, Eli Lilly continues to trade sideways at these inflated levels with the stock still boasting overly premium valuations, triggering a minimal margin of safety. While LLY's capacity expansions and M&A activiti...